The unique characteristics of the placental transcriptome and the hormonal metabolism enzymes in placenta

Reproductive Toxicology

Volumn 47, Issue , 2014, Pages 9-14

  Storvik, Markus ^a   Huuskonen, Pasi ^a   Pehkonen, Petri ^a   Pasanen, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

CYP19A1; Endocrine disruptors; Hormone; Placenta; Transcriptome

Indexed keywords

AROMATASE; TRANSCRIPTION FACTOR; ANDROGEN; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2C8; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 2J2; CYTOCHROME P450 4B1; ESTROGEN; STEROID HORMONE; TRANSCRIPTOME; XENOBIOTIC AGENT; HORMONE;

ARTICLE; BIOINFORMATICS; CYP19A1 GENE; DATA ANALYSIS; ENZYME ACTIVITY; FEMALE; GENE; GENETIC CODE; HORMONE METABOLISM; HUMAN; HUMAN TISSUE; LIVER; MICROARRAY ANALYSIS; PLACENTA FUNCTION; PROTEIN EXPRESSION; REGULATORY MECHANISM; RELIABILITY; TRANSCRIPTOMICS; XENOBIOTIC METABOLISM; CATALYSIS; ENZYME METABOLISM; GENE EXPRESSION; PLACENTA; GENETICS; METABOLISM; PREGNANCY;

CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HORMONES; HUMANS; LIVER; PLACENTA; PREGNANCY; TRANSCRIPTION FACTORS; TRANSCRIPTOME; XENOBIOTICS;

EID: 84901614664     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2014.04.010     Document Type: Article

References (38)

1. Sanderson J.T. Placental and fetal steroidogenesis. Methods Mol Biol 2009, 550:127-136.
2. Robins J.C., Marsit C.J., Padbury J.F., Sharma S.S. Endocrine disruptors, environmental oxygen, epigenetics and pregnancy. Front Biosci (Elite Ed) 2011, 3:690-700.
3. Leiser R., Kaufmann P. Placental structure: in a comparative aspect. Exp Clin Endocrinol 1994, 102(3):122-134.
4. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.H., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012, 33(3):378-455.
5. Zhang Y.Y., Yang L. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications. Expert Opin Drug Metab Toxicol 2009, 5(6):621-629.
6. Nelson D.R. Comparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution. Arch Biochem Biophys 2003, 409(1):18-24.
7. Nelson D.R. Progress in tracing the evolutionary paths of cytochrome P450. Biochim Biophys Acta 2011, 1814(1):14-18.
8. Myllynen P., Pasanen M., Vahakangas K. The fate and effects of xenobiotics in human placenta. Expert Opin Drug Metab Toxicol 2007, 3(3):331-346.
9. Pasanen M. The expression and regulation of drug metabolism in human placenta. Adv Drug Deliv Rev 1999, 38(1):81-97.
10. Paakki P., Kirkinen P., Helin H., Pelkonen O., Raunio H., Pasanen M. Antepartum glucocorticoid therapy suppresses human placental xenobiotic and steroid metabolizing enzymes. Placenta 2000, 21(2-3):241-246.
11. Paakki P., Stockmann H., Kantola M., Wagner P., Lauper U., Huch R., et al. Maternal drug abuse and human term placental xenobiotic and steroid metabolizing enzymes in vitro. Environ Health Perspect 2000, 108(2):141-145.
12. Pasanen M., Helin-Martikainen H.L., Pelkonen O., Kirkinen P. Intrahepatic cholestasis of pregnancy impairs the activities of human placental xenobiotic and steroid metabolizing enzymes in vitro. Placenta 1997, 18(1):37-41.
13. Huuskonen P., Storvik M., Reinisalo M., Honkakoski P., Rysä J., Hakkola J., et al. Microarray analysis of the global alterations in the gene expression in the placentas from cigarette-smoking mothers. Clin Pharmacol Ther 2008, 83(4):542-550.
14. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
15. Zhang J.Y., Wang Y., Prakash C. Xenobiotic-metabolizing enzymes in human lung. Curr Drug Metab 2006, 7(8):939-948.
16. Tolson A.H., Wang H. Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev 2010, 62(13):1238-1249.
17. Xu C., Li C.Y., Kong A.N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 2005, 28(3):249-268.
18. Pavek P., Dvorak Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab 2008, 9(2):129-143.
19. Harada N., Yoshimura N., Honda S.J. Unique regulation of expression of human aromatase in the placenta. Steroid Biochem Mol Biol 2003, 86(3-5):327-334.
20. Bamberger A.M., Makrigiannakis A., Schröder M., Bamberger C.M., Relakis C., Gellersen B., et al. Expression pattern of the CCAAT/enhancer-binding proteins C/EBP-alpha, C/EBP-beta and C/EBP-delta in the human placenta. Virchows Arch 2004, 444(2):149-152.
21. Begay V., Smink J., Leutz A. Essential requirement of CCAAT/enhancer binding proteins in embryogenesis. Mol Cell Biol 2004, 24:9744-9751.
22. Bagchi M.K., Mantena S.R., Kannan A., Bagchi I.C. Control of uterine cell proliferation and differentiation by C/EBPbeta: functional implications for establishment of early pregnancy. Cell Cycle 2006, 5:922-925.
23. Chakrabarty A., Roberts M.R. Ets-2 and C/EBP-beta are important mediators of ovine trophoblast Kunitz domain protein-1 gene expression in trophoblast. BMC Mol Biol 2007, 8:14.
24. Ramathal C., Wang W., Hunt E., Bagchi I.C., Bagchi M.K. Transcription factor CCAAT enhancer-binding protein beta (C/EBPbeta) regulates the formation of a unique extracellular matrix that controls uterine stromal differentiation and embryo implantation. J Biol Chem 2011, 286:19860-19871.
25. Lau C.A., Abbott B.D., Corton J.C., Cunningham M.L. PPARs and xenobiotic-induced adverse effects: relevance to human health. PPAR Res 2010, 954639.
26. Nakanishi T. Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor. J Toxicol Sci 2008, 33(3):269-276.
27. Kwintkiewicz J.N., Nishi Y., Yanase T., Giudice L.C. Peroxisome proliferator-activated receptor-gamma mediates bisphenol A inhibition of FSH-stimulated IGF-1: aromatase, and estradiol in human granulosa cells. Environ Health Perspect 2010, 118(3):400-406.
28. Kim H.G., Han E.H., Jeong H.G. Effect of troglitazone on CYP1A1 induction. Toxicology 2008, 246(2-3):166-171.
29. Storvik M., Huuskonen P., Kyllönen T., Lehtonen S., El-Nezami H., Auriola S., et al. Aflatoxin B1-a potential endocrine disruptor-up-regulates CYP19A1 in JEG-3 cells. Toxicol Lett 2011, 202(3):161-167.
30. Nguyen L.P., Bradfield C.A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 2008, 21:102-116.
31. Nishimura M., Naito S. Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab Pharmacokinet 2006, 21(5):357-374.
32. Obolenskaya M.Y., Teplyuk N.M., Divi R.L., Poirier M.C., Filimonova N.B., Zadrozna M., et al. Human placental glutathione S-transferase activity and polycyclic aromatic hydrocarbon DNA adducts as biomarkers for environmental oxidative stress in placentas from pregnant women living in radioactivity- and chemically-polluted regions. Toxicol Lett 2010, 196(2):80-86.
33. Milne G.L., Zanoni G., Porta A., Sasi S., Vidari G., Musiek E.S., et al. The cyclopentenone product of lipid peroxidation: 15-A2t-isoprostane, is efficiently metabolized by HepG2 cells via conjugation with glutathione. Chem Res Toxicol 2004, 17(1):17-25.
34. Ferguson C.S., Tyndale R.F. Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci 2011, 32(12):708-714.
35. Williams G.C., Nesse R.M. The dawn of Darwinian medicine. Q Rev Biol 1991, 66(1):1-22.
36. Xu C., Li C.Y., Kong A.N. Induction of phase I II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 2005, 28(3):249-268.
37. Antolin M.F., Jenkins K.P., Bergstrom C.T., Crespi B.J., De S., Hancock A., et al. Evolution and medicine in undergraduate education: a prescription for all biology students. Evolution 2012, 66(6):1991-2006.
38. Seliskar M., Rozman D. Mammalian cytochromes P450--importance of tissue specificity. Biochim Biophys Acta 2007, 1770(3):458-466.